Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2020

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2021

H(2)S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma

por Yang, Dan, Li, Tianqi, Li, Yinlong, Zhang, Shengnan, Li, Weirui, Liang, Heng, Xing, Zikang, Du, Lisha, He, Jinchao, Kuang, Chunxiang, Yang, Qing
Publicado 2019

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor b...

por Li, Weirui, Guo, Leilei, Xing, Zikang, Fang, Xin, Liang, Heng, Zhang, Shengnan, Shi, Lei, Kuang, Chunxiang, Shi, Leming, Zheng, Yuanting, Hu, Yueqing, Yang, Qing
Publicado 2021